Showcasing LVV Turbo at CAR-TCR Summit 2025

September 23, 2025

From LVV Turbo to CAR-TCR Solutions: uBriGene to Showcase Innovation at CAR-TCR Summit 2025 in Boston

uBriGene is proud to announce our participation in the 10th Anniversary CAR-TCR Summit, taking place September 23–26, 2025, in Boston, MA. This premier event brings together global leaders in cell and gene therapy to explore the latest advancements in CAR-T and TCR therapies.

At the summit, uBriGene will highlight our latest innovations through:

Scientific Poster Presentation
Development of a high-yield cGMP lentiviral vector manufacturing process using suspension culture, a packaging enhancer, and a closed aseptic system
📅 September 23, 2025 | 6:30 PM

Private Lunch & Learn
Discover how uBriGene is your one-stop CDMO partner for CAR-TCR T cell and NK cell therapies, powered by our LVV Turbo production system capable of delivering up to 1,500 CAR-T doses from a single 20 L production run.
📅 September 24, 2025 | 12:45 – 1:45 PM

uBriGene is a leading global CDMO specializing in viral vector platforms, iPSC tools, and end-to-end CAR-TCR cell therapy solutions. With extensive CMC expertise, we help our partners accelerate development and scale manufacturing with innovation, scalability, and quality at the core.

Join us in Boston to learn how uBriGene can support your journey from discovery to GMP manufacturing.

Learn more about the event at 10th Anniversary CAR-TCR Summit